3320.HK 財務： China Resources Pharmaceutical Group Limited AI 分析

Q: 技術分析指標如何適用於 3320.HK？

根據技術分析，China Resources Pharmaceutical Group Limited 的綜合信號為 Sell。China Resources Pharmaceutical Group Limited 有 2 個買入信號，2 個中性信號和 3 個賣出信號。

Q: 3320.HK 的費波那契回檔水準是多少？

China Resources Pharmaceutical Group Limited 的費波那契回檔水準是 介於 0% 和 23.6% 之間。

Q: China Resources Pharmaceutical Group Limited 的 RSI 是多少？

China Resources Pharmaceutical Group Limited 的 RSI 目前為 39.99，表明處於 中立 狀態

Q: China Resources Pharmaceutical Group Limited 接下來 12 個月的價格是多少？

China Resources Pharmaceutical Group Limited 3320.HK 接下來 12 個月的價格預估為 $6.8。

Q: China Resources Pharmaceutical Group Limited 預計會漲到多高？

據華爾街分析師稱，China Resources Pharmaceutical Group Limited 預計將達到 $9.24 的高預測值。

首頁

股票

3320.HK

預測

CHINARES PHARMA (3320.HK)

China Resources Pharmaceutical Group Limited

HK$4.54

0.22%

$0

休市： Jan 19, 16:00:00 HKT

關鍵數據

前收市價

$4.54

開盤價

$4.53

當日範圍

$4.49 - $4.57

52週區間

$4.35 - $5.76

交易量

7.5M

平均成交量

12.6M

每股盈餘 (TTM)

0.50

股息收益率

市值

$28.5B

什麼是 CHINARES PHARMA？

China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and healthcare products. The firm operates its business through four segments. The Pharmaceutical Business segment develops, manufactures and sells a range of pharmaceuticals and health products. The Pharmaceutical Distribution Business segment provides distribution, warehousing, logistics and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers, device manufacturer and dispensers, including hospitals, distributors and retail pharmacies. The Pharmaceutical Retail Business segment operates retail pharmacies. The Other Business Operations segment engages in property holding and other businesses.

功能特性

交易策略

資源

市場

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for 3320.HK in the upcoming periods. Looking toward the future, our 2027 projection indicates an average price target of $6.8. The lowest target is $5.65 and the highest is $9.24. Empower your investment choices with our cutting-edge, data-driven analysis!

3320.HK 股價預測摘要

3320.HK 的頂級分析師評級

根據 17 位分析師對 3320.HK 的股票評級，更新於 Jan 01, 2026

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for 3320.HK. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: 3320.HK is a Buy candidate.

3320.HK stock price ended at $4.55 on 星期一, after rising 0.22%

On the latest trading day Jan 19, 2026, the stock price of 3320.HK rose by 0.22%, climbing from $4.59 to $4.55. Throughout the session, the stock experienced a volatility of 2.23%, with prices fluctuating between a daily low of $4.49 and a high of $4.59. Alongside this price increase, trading volume also rose by 11.6M shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 2.2M shares were traded, amounting to a market value of approximately $28.5B.

3320.HK 技術面訊號

技術面訊號摘要

購買訊號 2

中性訊號 2

賣出訊號 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

3320.HK 目前顯示 2 個買入訊號與 3 個賣出訊號。該股票自 12:00 AM 以來一直處於上升趨勢狀態，在此期間價格總共變動了 0.22%。整體而言，技術指標顯示中期後市趨勢為 Sell。

3320.HK 的看漲／看跌訊號

我們的演算法透過分析移動平均線、RSI、MACD 和成交量等關鍵指標，為3320.HK生成看漲和看跌訊號。這些見解可助您做出明智的投資決策。

後續問題

技術分析指標如何適用於 3320.HK？



3320.HK 的費波那契回檔水準是多少？



China Resources Pharmaceutical Group Limited 的 RSI 是多少？



China Resources Pharmaceutical Group Limited 接下來 12 個月的價格是多少？



China Resources Pharmaceutical Group Limited 預計會漲到多高？



China Resources Pharmaceutical Group Limited（3320.HK）價格

3320.HK 股價走勢圖